Lexicon Pharmaceuticals
LXRX
LXRX
98 hedge funds and large institutions have $357M invested in Lexicon Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 39 increasing their positions, 22 reducing their positions, and 8 closing their positions.
Holders
98
Holders Change
+12
Holders Change %
+13.95%
% of All Funds
1.69%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
21
Increased
39
Reduced
22
Closed
8
Calls
$287K
Puts
$87K
Net Calls
+$200K
Net Calls Change
-$146K
Top Buyers
1 |
AG
1
Artal Group
Luxembourg
|
$215M |
2 |
2
Point72 Asset Management
Stamford,
Connecticut
|
$8.67M |
3 |
![]()
3
JPMorgan Chase & Co
New York
|
$7.74M |
4 |
BI
4
BVF Inc
San Francisco,
California
|
$38.8M |
5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$12.6M |